Israel Scientific Study: Cannabis Safe and Effective for Regular Use in the Elderly; Can Decrease the Use of Other Prescription Medicines, Including Opioids

A new published clinical study out of Israel offers scientific evidence that the therapeutic use of cannabis can be a safe and effective treatment for elderly people, and is often a factor leading to the decreased use of other drugs, including opioids.

Cronos Announces Exchange Approval for Cronos Israel and Key Additions to Senior Leadership Team

Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos" or the "Company") is pleased to announce that its previously announced strategic joint venture ("Cronos Israel") with Kibbutz Gan Shmuel ("Gan Shmuel") for the production, manufacture, and global distribution of medical cannabis, has been approved by the TSX Venture Exchange.  

Israel Plants Its Flag In the U.S. Cannabis Industry

For more than 50 years, Israeli scientists have been researching the medical benefits associated with cannabis and the country’s pro-cannabis standpoint has made it attractive to several cannabis-focused biotech firms.

Although the Israeli cannabis research and development efforts are unmatched by any country, the growth of the North American cannabis industry has caught Israel’s attention.

Bellwether of the Biotechs: GW Pharma

2017 has been a year to remember for the stock market and we are not even at the halfway point…

From Israel to Canada, from the U.K. to the U.S., we continue to see life-changing developments within the biotech industry. The culprit for these incredible developments is not who most would expect though. The reason why is not due to it being new. It is because it is illegal.

Israeli Biotech Is A Boomin'

Although Canadian cannabis stocks have been the story to watch over the last year, Israeli cannabis stocks have been stealing headlines in 2017.  

Today, United States traded Israeli cannabis company, OWC Pharmaceutical Research (OWCP) reported that the results of its topical cream efficacy tests show a significant reduction of several inflammation markers specific to psoriasis.